Coming Soon · Phase 3 Data
28.7% mean body weight loss in TRIUMPH-4. A board-certified internist breaks down Lilly’s triple GLP-1/GIP/glucagon agonist, the NEJM data, and the FDA approval timeline.
Dr. Teja Surapaneni · May 2026 · 12 min read
Read Article →
Weight Loss
Every FDA-approved GLP-1: Wegovy, Wegovy HD, Zepbound, Wegovy Pill, and Foundayo. Clinical data, cost, and how to choose the right one.
Dr. Teja Surapaneni · May 2026 · 10 min read
Read Article →
Weight Loss
Two FDA-approved oral GLP-1s with different mechanisms. A physician compares clinical data, food restrictions, cost, and prescribing logic.
Dr. Teja Surapaneni · May 2026 · 8 min read
Read Article →
Weight Loss
FDA-approved April 2026. The first GLP-1 with zero food or water timing restrictions. Dosing, cost, and who qualifies.
Dr. Teja Surapaneni · May 2026 · 7 min read
Read Article →
Weight Loss
FDA-approved March 2026. 20.7% mean weight loss for patients who plateau on standard Wegovy. What to know about dysesthesia.
Dr. Teja Surapaneni · May 2026 · 6 min read
Read Article →
Weight Loss
Tirzepatide approved December 2024 for moderate-to-severe OSA. Up to 50% of patients no longer met OSA criteria after one year.
Dr. Teja Surapaneni · May 2026 · 7 min read
Read Article →
Weight Loss
A month-by-month timeline of what to expect on semaglutide, from Week 1 appetite changes through Month 12 maintenance.
Dr. Teja Surapaneni · 2026 · 6 min read
Read Article →
Weight Loss
What your doctor wants you to know about the GLP-1 shortage, 503A vs 503B pharmacies, and why YourMD prescribes only FDA-approved branded GLP-1 medications.
Dr. Teja Surapaneni · 2026 · 7 min read
Read Article →
Weight Loss
10+ evidence-based strategies to manage GLP-1 nausea, from dietary changes to prescription anti-nausea medications.
Dr. Teja Surapaneni · 2026 · 5 min read
Read Article →
Weight Loss
What to eat on semaglutide or tirzepatide to maximize results, prevent muscle loss, and minimize side effects.
Dr. Teja Surapaneni · 2026 · 6 min read
Read Article →
Men’s Health
Week-by-week timeline of daily tadalafil, from first dose through full therapeutic effect and BPH symptom relief.
Dr. Teja Surapaneni · 2026 · 5 min read
Read Article →
Men’s Health
How sublingual troches compare to standard tablets in onset time, bioavailability, food interactions, and convenience.
Dr. Teja Surapaneni · 2026 · 5 min read
Read Article →
Hair Loss
Why combination therapy works better than either alone, how to combine them, and what results to expect.
Dr. Teja Surapaneni · 2026 · 6 min read
Read Article →
Longevity
The most studied longevity drug in preclinical research. What the animal and early human evidence shows, and how physicians are using it off-label.
Dr. Teja Surapaneni · 2026 · 8 min read
Read Article →
Longevity
A 60-year-old diabetes drug that may slow aging. Review of the TAME trial, observational evidence, dosing, and what physicians think.
Dr. Teja Surapaneni · 2026 · 7 min read
Read Article →
Skincare
Why your skin gets worse before it gets better on tretinoin, how long the purge lasts, and evidence-based strategies to minimize it.
Dr. Teja Surapaneni · 2026 · 5 min read
Read Article →
Clinical Philosophy
YourMD takes an evidence-first approach to every treatment. Here’s why we say no more often than our competitors — and why that matters for your health.
Dr. Teja Surapaneni · April 2026 · 5 min read
Read Article →
Weight Loss
A physician explains the GLP-1 mechanism, STEP 1 trial data (14.9% weight loss), candidacy criteria, and what to expect month by month.
Dr. Teja Surapaneni · May 2026 · 8 min read
Read Article →
Weight Loss
22.5% average weight loss at the highest dose. A physician explains tirzepatide’s dual mechanism, SURMOUNT data, and how it compares to semaglutide.
Dr. Teja Surapaneni · May 2026 · 8 min read
Read Article →
Men’s Health
Duration, dosing flexibility, food interactions, side effects, and which is right for you — including the case for daily tadalafil 5 mg.
Dr. Teja Surapaneni · May 2026 · 7 min read
Read Article →
Hair Loss
How finasteride blocks DHT to slow male pattern hair loss, Phase 3 clinical results, realistic side effect risk, and who is a candidate.
Dr. Teja Surapaneni · May 2026 · 8 min read
Read Article →
Skincare
FDA-approved since 1971. How it works for acne and photoaging, the retinization period, and why it outperforms OTC retinol.
Dr. Teja Surapaneni · May 2026 · 7 min read
Read Article →
Vitality
NAD+ is one of the most searched wellness therapies of 2026. A board-certified internist separates the compelling cellular biology from the limited human trial data — and explains when a physician-supervised injection makes sense.
Dr. Teja Surapaneni · June 2026 · 9 min read
Read Article →
Hypertension
The 2025 ACC/AHA guidelines give telehealth a Class I recommendation for blood pressure control. A physician explains what that means for patients.
Dr. Teja Surapaneni · June 2026 · 10 min read
Read Article →
Peptide Therapy
Sermorelin stimulates your pituitary to produce growth hormone naturally — unlike HGH injections which replace it directly. A physician explains the clinical and regulatory difference.
Dr. Teja Surapaneni · June 2026 · 10 min read
Read Article →
Cardiology
High LDL has no symptoms until it causes a heart attack. A board-certified internist explains telehealth lipid management — labs, statin selection, non-statin options, and lifestyle changes that actually move the numbers.
Dr. Teja Surapaneni · June 2026 · 9 min read
Read Article →
Weight Loss
Coverage for GLP-1 weight-loss medications varies by plan, employer, and state. A physician explains the prior authorization process, what to do if denied, and how to use NovoCare and LillyDirect™ to reduce your cost.
Dr. Teja Surapaneni · June 2026 · 8 min read
Read Article →
Weight Loss
Wegovy lists at $1,349/month. Here’s what actually reduces your cost — the NovoCare savings card, LillyDirect™ Zepbound pricing, the truth about compounded semaglutide in 2026, and the open enrollment strategy most patients miss.
Dr. Teja Surapaneni · June 2026 · 9 min read
Read Article →
Telehealth
Internists manage hypertension, diabetes, high cholesterol, thyroid, and preventive care. Here’s what a video visit with a board-certified internist covers, how to prepare, and when you still need to go in person.
Dr. Teja Surapaneni · June 2026 · 8 min read
Read Article →
Hair Loss
Female hair loss is underdiagnosed and undertreated. A board-certified internist explains androgenetic alopecia, telogen effluvium, thyroid and iron deficiency, and which treatments have real evidence.
Dr. Teja Surapaneni · June 2026 · 10 min read
Read Article →
Weight Loss
Wegovy lists at $1,349/month. The NovoCare savings program brings this to $349 — or $199 for new starts. A physician explains every legitimate savings pathway including Foundayo™ and oral GLP-1 alternatives.
Dr. Teja Surapaneni · June 2026 · 9 min read
Read Article →
Women’s Health
PT-141 (bremelanotide/Vyleesi®) is the only non-hormonal FDA-approved treatment for HSDD. A physician reviews the Phase 3 RECONNECT trials, how it compares to Addyi, dosing, and side effects.
Dr. Teja Surapaneni · June 2026 · 11 min read
Read Article →
Hair Loss
Female pattern hair loss affects 1 in 3 women over 50 but is rarely treated with evidence-based medication. A physician explains finasteride in women — the evidence, the absolute pregnancy contraindication, and first-line options.
Dr. Teja Surapaneni · June 2026 · 9 min read
Read Article →
Telehealth
Most DTC telehealth uses NPs following protocols. A board-certified internist explains why ABIM training is different — and what that means when your case doesn’t fit a protocol.
Dr. Teja Surapaneni · June 2026 · 8 min read
Read Article →
Men's Health
FDA-approved for both ED and BPH, once-daily tadalafil 5mg reduces urinary symptoms and improves sexual function simultaneously. Complete guide to dosing, evidence, and what to expect.
Dr. Teja Surapaneni · June 2026 · 7 min read
Read Article →
Dermatology
Retinol is OTC and slow. Tretinoin is prescription-strength and clinically proven for wrinkles, acne, and hyperpigmentation. A dermatology-based breakdown of the evidence and how to start safely.
Dr. Teja Surapaneni · June 2026 · 6 min read
Read Article →
Weight Loss
Metformin is inexpensive, safe, and produces modest but real weight loss in non-diabetic patients — especially when combined with GLP-1s. Evidence review, realistic expectations, and who is a good candidate.
Dr. Teja Surapaneni · June 2026 · 7 min read
Read Article →
Diabetes Care
Ozempic (semaglutide) lowers A1C 1.5–2%, reduces cardiovascular events, and slows CKD progression. What the ADA 2026 Standards actually recommend, how to start, manage side effects, and get it covered.
Dr. Teja Surapaneni · June 2026 · 9 min read
Read Article →
Vitality
Glutathione is the body's master antioxidant. IV and IM injections bypass GI absorption limits. What the clinical evidence actually shows about skin brightening, detoxification, energy, and NAD+ synergy.
Dr. Teja Surapaneni · June 2026 · 7 min read
Read Article →
Women's Health
The 2025 NAMS position statement confirmed HRT is safe for most women under 60 and within 10 years of menopause. Estrogen, progesterone, and testosterone options, delivery methods, and how to start.
Dr. Teja Surapaneni · June 2026 · 9 min read
Read Article →
Weight Loss
Nausea is the #1 reason patients quit GLP-1s in the first 8 weeks. Ondansetron 4mg PRN is off-label but evidence-supported. Timing, dosing protocol, and when to escalate to dose reduction instead.
Dr. Teja Surapaneni · June 2026 · 6 min read
Read Article →
Weight Loss
The monthly headline price rarely tells the full story. A board-certified physician breaks down the two pricing models, every cost component, and 10 questions to ask any platform before subscribing.
Dr. Teja Surapaneni · June 2026 · 10 min read
Read Article →
About YourMD
A board-certified internist walks through every step between your intake and your prescription — the safety screens, contraindication hard blocks, physician review process, and exactly when and why we say no.
Dr. Teja Surapaneni · June 2026 · 8 min read
Read Article →
Getting Started
From creating your account to receiving your prescription — a step-by-step walkthrough of your first visit, what your physician reviews, what to have ready, and what happens after.
Dr. Teja Surapaneni · June 2026 · 7 min read
Read Article →
About YourMD
Compounded semaglutide was a legitimate option during the 2022–2024 shortage. It is not in 2026. The regulatory history, the FDA safety record, what changed, and why this is a permanent clinical policy.
Dr. Teja Surapaneni · June 2026 · 8 min read
Read Article →
Privacy & Security
HIPAA, encryption in transit and at rest, business associate agreements, your rights, what we will never do with your data, and what happens if a breach occurs — in plain language.
Dr. Teja Surapaneni · June 2026 · 7 min read
Read Article →
About YourMD
Board-certified internist, former lead hospitalist at Southwest Medical Associates (Optum/UHC), 10,000+ telehealth consultations, founder of United Medical Group and YourMD. The full background on the physician reviewing every prescription.
Dr. Teja Surapaneni · June 2026 · 9 min read
Read Article →